Clinical Trial Update: The Novel Immunomodulatory and Anticoagulant Therapies for Recurrent Pregnancy Loss [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on novel immunomodulatory and anticoagulant therapies for recurrent pregnancy loss. Current status of the study is UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pregnancy Loss

Snippet

Sponsor: Shanghai First Maternity and Infant Hospital | Conditions: Recurrent Pregnancy Loss | Phase 4 | Status: UNKNOWN